thalidomide has been researched along with 1-methyl-4-phenylpyridinium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feldon, J; Ferger, B; Hengerer, B; Leng, A; Mura, A | 1 |
1 other study(ies) available for thalidomide and 1-methyl-4-phenylpyridinium
Article | Year |
---|---|
Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Dopamine; Dopamine Plasma Membrane Transport Proteins; Glial Fibrillary Acidic Protein; Immunosuppressive Agents; Macrophage-1 Antigen; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; MPTP Poisoning; Neostriatum; Nerve Tissue Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Thalidomide; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2004 |